Enzon and Viskase amend merger agreement terms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Enzon and Viskase Announce Amendment to Merger Agreement
October 24, 2025 4:50 PM EDTCRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (Enzon or the Company) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (Viskase) today announced that they have entered into an amendment (the Amendment) to the previously disclosed Agreement and Plan of Merger (the Merger Agreement), pursuant to which Viskase will merge with and into a wholly owned subsidiary of Enzon in an all-stock transaction (the Merger). The Amendment was entered into to reflect recent developments in the operations of Viskase during the past several... More
